arrow-left

Q2FY23 Preview: Apollo Hospitals Enterprise: Revenue seen at Rs41,154 million, PAT at Rs2,326 million

  • India Infoline News Service |
  • 09 Nov, 2022 |
  • 3:06 PM
Result date: 10th November, 2022
Recommendation: Buy
Target price: Rs4,815
(Source: IIFL Research)
 
For the September 2022 quarter, Apollo Hospitals Enterprise (Apollo Hospitals) could witness sequential improvement in occupancy. Strong growth in standalone pharmacies and double digit growth in AHLL could drive ~11% year-on-year growth in revenue.

Continued losses in the 24x7 segment could hit overall profitability of the company. Excluding these, EBITDA could grow in mid-single digits.

Apollo Hospitals could report a 6% drop in its Profit After Tax (PAT) over the year-ago quarter.

Important management insights to watch out for:
  • Growth outlook for key business segments
  • Spends towards 24/7 (digital health platform) and its breakeven
Rs. Million September 2022 estimates QoQ change YoY change
Revenue 41,154 8.43% 10.70%
EBITDA 5,711 16.37% (7.10)%
Profit After Tax 2,326 (7.37)% (6.13)%
Source: Brokerage Reports

Invest wise with Expert advice

ad IconAd Image

Most Read News

Article Image
  • 14 March, 2022 |
  • 7:03 AM

The US Federal committee's meeting will conclude on March 16, 2022.

Most Shared News

No Record Found